DexCom Sees Q3 2024 Revenue $975M-$1.00B vs $1.15B Est.
Portfolio Pulse from Benzinga Newsdesk
DexCom has announced its Q3 2024 revenue forecast to be between $975 million and $1.00 billion, which is below the estimated $1.15 billion.
July 25, 2024 | 8:27 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
DexCom's Q3 2024 revenue forecast of $975M-$1.00B is below the estimated $1.15B, which may negatively impact investor sentiment and the stock price in the short term.
The revenue forecast being below estimates suggests potential challenges in meeting market expectations, which could lead to a negative reaction from investors and a decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100